New Disorders Workgroup Winter Webinar Series Part Two: Considerations for Infectious Disease Screening or Monitoring in the Newborn Screening Program
The Association of Public Health Laboratories (APHL) Newborn Screening Technical assistance and Evaluation Program (NewSTEPs) is pleased to announce the second webinar in the New Disorders Workgroup Winter Webinar Series on Thursday, February 4 at 2:00 pm ET. This three-part webinar series will provide updates from programs screening for disorders not currently on the RUSP, both as pilot programs and as components of universal screening. This series will end with a discussion of future disorders that have been nominated for review by the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) and/or are in current pilots.
This webinar will provide an overview of infectious diseases being screened for by newborn screening programs. Speakers will focus on the screening considerations for infectious diseases such as Congenital Cytomegalovirus (cCMV) and Human Immunodeficiency Virus (HIV). New uses of dried blood spots in COVID-19 efforts will also be presented.
At the conclusion of the program, the participant will be able to:
- Review screening considerations for cCMV, HIV, and other infectious diseases
- Discuss the application of the newborn screening dried blood spots in state COVID-19 activities
- Discuss the role of the newborn screening program in the monitoring and follow-up of infectious diseases
- Describe state pilot activities for cCMV and COVID-19
Link to archived webinar: http://www.aphl.org/601-21
Sondra Rosendahl, MS, CGC, Licensed, Certified Genetic Counselor, Minnesota Public Health Laboratory
Stanley Sciortino, PhD, MPH, Chief, Program and Evaluation Section, Genetic Disease Screening Program, California Department of Public Health
Colleen Stevens, PhD, Lead Scientist, NYS Newborn Screening Molecular Laboratory, Wadsworth Center, New York State Department of Health
Linda Styer, PhD, Associate Director, Bloodborne Viruses Laboratory, Wadsworth Center, New York State Department of Health
APHL is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E® Program, Florida and CPH recertification. P.A.C.E® is accepted by all licensure states except Florida. If approved, this webinar will provide 1.5 contact hour for participants who successfully complete this webinar. The deadline to receive P.A.C.E for the archived webinar is February 4, 2022.
This resource is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant # U22MC24078. This information or content and conclusions are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the US Government.